Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)

NCT01765361 · clinicaltrials.gov ↗
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University Hospital, Basel, Switzerland